abstract |
The present invention relates to general formula (I) Novel substituted fused pyrimidine compounds of the formula, wherein the chemical groups, substituents, and subscripts are as defined herein, and conditions and diseases that can be treated by inhibition of pharmaceuticals, particularly the PDE4 enzyme Relates to its use as a medicament for treating. |